Ozempic Anesthesia: How Your Team Decides What to Do With Your Dose

Planning for Ozempic anesthesia starts with one question: what is in your stomach when you go under? Semaglutide slows gastric emptying, so food and fluid can stay in your stomach longer than usual. The prescribing information for Ozempic describes this delay, and it is the reason anesthesia teams look at GLP-1 drugs differently than they used to. This post covers the decision itself, not the disclosure checklist, so you can understand how the call gets made and what to ask on the day.

Why GLP-1 drugs change the anesthesia conversation

The main concern is pulmonary aspiration, which means stomach contents entering the lungs during induction of anesthesia. When you are sedated, the protective reflexes that normally keep stomach contents out of the airway are reduced. If the stomach is still full, the risk goes up. That is the logic behind the guidance, and it is also why the risk is not identical for everyone.

The slowing from semaglutide can vary from person to person. Some people notice little effect, while others have more bloating or early fullness, especially in the weeks after a dose increase. Because of that variation, your anesthesia team is less interested in the drug name alone and more interested in how your body is handling it right now.

What the major guidance says and how it has changed

The 2023 guidance from the American Society of Anesthesiologists (ASA) advised holding the weekly GLP-1 dose for one week before elective procedures. That was a clear, blanket rule, and many patients heard it directly from their surgeons. Later, a multisociety update published in 2024 moved toward individualized decisions. Under that approach, many patients may continue the drug, while higher-risk patients may be asked to follow a liquid diet for about 24 hours before the procedure. If you want to see how these recommendations have shifted over time, OzemNews has covered each change as it arrived, and that history helps explain why two hospitals can give you different instructions.

Local practice varies, and the final decision rests with your anesthesiologist and surgeon. Brazilian guidance may not match the international documents word for word. The Brazilian Society of Anesthesiology (SBA) is the body to check for any position it has issued on GLP-1 agonists. I could not confirm the exact wording of an SBA position while writing this, so ask your anesthesia team which document they follow and read the exact text yourself. Hospital protocols in Brazil can also differ from one institution to the next.

How the anesthesiologist assesses risk on the day

On the day of surgery, the team usually starts with a symptom screen. They will ask about nausea, vomiting, bloating, abdominal discomfort, or feeling full early in meals during the days before the procedure. Those answers matter because they can suggest that your stomach is not emptying as expected.

Next, they look at your dose details: the date of your last injection, your current dose, and whether the dose was recently increased. A recent escalation is worth flagging, since side effects tend to be more noticeable during that period.

Where it is available, a gastric ultrasound can estimate stomach contents at the bedside. It is a quick look that helps the team decide whether to proceed as planned, delay, or take extra steps. Availability varies a lot by hospital, so do not assume your center has it. The timing of the procedure also shapes the plan. Elective cases allow more time for preparation. Urgent or emergency cases may proceed with a rapid sequence induction, a technique designed to secure the airway quickly, along with other precautions. Your team decides which approach fits your situation.

When diabetes medications complicate the plan

If you also take insulin or a sulfonylurea, the fasting period adds a separate concern: low blood sugar. Checking glucose on the fasting day matters, and your team will tell you how often to check and what to do if the number drops. Symptoms of hypoglycemia can include shakiness, sweating, confusion, a fast heartbeat, and sudden hunger. Tell someone at the hospital right away if you notice them.

Metformin, when used alongside semaglutide, often has its own holding rules around surgery and contrast imaging. These rules depend on your kidney function and the procedure, so the hospital protocol should guide the decision. If you are trying to understand how these combinations fit together, the OzemNews guide to combinations is a useful starting point before you sit down with your prescriber. Glucose targets and monitoring frequency also follow institutional protocols, so ask which schedule applies to you. Current guidance from the American Diabetes Association, in its Standards of Care, covers perioperative and hospital glucose management in more detail.

Questions to bring to the pre-op appointment

Walking into the pre-op visit with written questions makes the conversation easier. You can grab a printable question sheet from OzemNews (https://ozemnews.com) and fill it in before your appointment. Start with the basics. When was your last injection, and does the team want your dose records or pen details? Then ask whether you should follow a liquid diet and for how long before the procedure, since fasting language can differ between hospitals.

Ask what happens if you feel bloated or nauseated when you arrive. Some teams may reschedule, while others may proceed with added precautions. Ask whether they plan a rapid sequence induction or other measures for you. Finally, ask who to call if the surgeon's fasting instructions and the anesthesia instructions conflict. Having that phone number before surgery day can prevent confusion at the last minute.

After surgery: eating, nausea, and restarting the dose

Nausea after surgery is common, and it can overlap with the gastrointestinal side effects listed in the Ozempic label. That overlap makes it hard to tell at home whether the cause is anesthesia, pain medication, or semaglutide. Keep a short note of what you eat, when you feel sick, and what helps.

Restarting the weekly dose depends on how well you tolerate food and fluids by mouth, along with your prescriber's instructions. Do not restart on your own timeline. Confirm the plan with the team that manages your medication before you inject again.

Contact your medical team promptly if you have any of these warning signs:

• Vomiting that does not stop
• Severe or worsening abdominal pain
• Inability to keep fluids down

Signs of dehydration, such as dizziness, very dark urine, or a dry mouth, also deserve a call. Your discharge instructions will list the specific numbers to call and when to go to the emergency room, so keep them where you can find them.

FAQ

Do I always have to stop Ozempic before surgery?

Not always. The 2023 ASA guidance advised holding the weekly dose for one week before elective procedures, but a 2024 multisociety update favors individualized decisions. Many patients may continue the drug, and your anesthesia team and surgeon decide what fits your case.

Will I need a liquid diet before my procedure?

Some higher-risk patients may be asked to follow a liquid diet for about 24 hours before the procedure. Ask your team whether that applies to you and follow the written instructions you receive.

Should I mention nausea or bloating in the days before surgery?

Yes. Those symptoms can change the plan, including whether the team proceeds, delays, or adds precautions. Reporting them early gives the team more options.

Can I restart Ozempic on my own after surgery?

It is better not to. Restarting depends on how well you tolerate food and fluids and on your prescriber's instructions, so confirm the timing before your next injection.

Sources

• Ozempic (semaglutide) prescribing information, Drugs@FDA
• Bulário eletrônico, ANVISA
• American Society of Anesthesiologists (ASA)
• Sociedade Brasileira de Anestesiologia (SBA)
• American Diabetes Association, Standards of Care in Diabetes